The two faces of α- and γ-tocopherols: An in vitro and ex vivo investigation into VLDL, LDL and HDL oxidation

Journal of Nutritional Biochemistry

Volumn 23, Issue 7, 2012, Pages 845-851

  Nadeem, Nida ^a   Woodside, Jayne V ^a   Kelly, Sean ^a   Allister, Rachael ^a   Young, Ian S ^a   McEneny, Jane ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antioxidants; Lipoprotein oxidation; Pro oxidant activity; Tocopherol

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LIPID BLOOD LEVEL; LIPID OXIDATION; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL;

ALPHA-TOCOPHEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; GAMMA-TOCOPHEROL; HUMANS; LIPID METABOLISM; LIPOPROTEINS, VLDL; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; VITAMINS;

EID: 84862335630     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.04.009     Document Type: Article

References (46)

1. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Nat Acad Sci USA 1987, 84:2995-2998.
2. Diaz M.N., Frei B., Vita J.A., Keaney J.F. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997, 337:408-416.
3. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915-924.
4. Reaven P.D., Witztum J.L. Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation. Arterioscler Thromb Vas Biol 1993, 13:601-608.
5. Stephens N.G., Parsons A., Schofield P.M., et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347:781-786.
6. Salonen J.T.K., Nyyssonen R., Salonen H.M., Lakka J., Kaikkonen E., Porkkala-Sarataho S, Voutilainen T.A., Lakka T., Rissanen L., Leskinen T.P., Tuomainen V.P., Valkonen U., Ristonmaa U., Poulsen H.E. Antioxidant SUPPL.ementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000, 248:377-386.
7. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M.S. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000, 356:1213-1218.
8. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455.
9. The HOPE and HOPE-TOO Trial Investigators Effects of long term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293:1338-1347.
10. Rapola J.M., Virtamo J., Haukka J.K., Heinonen O.P., Albanes D., Taylor P.R., Huttunen J.K. Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial. JAMA 1996, 275:693-698.
11. Jiang Q., Christen S., Shigenaga M.K., Ames B.N. γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001, 74:714-722.
12. Wagner K.H., Kamal-Eldin A., Elmada I. Gamma-tocopherol - an underestimated vitamin?. Ann Nutr Metab 2004, 48:169-188.
13. Ohrvall M., Sundlof G., Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 1996, 239:111-117.
14. Kontush A., Spranger T., Reich A., Baum K., Beisegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma tocopherol. Atherosclerosis 1999, 144:117-122.
15. Saldeen T., Dayuan Li, Mehta J.L. Differential effects of alpha and gamma tocopherol on low density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardio 1999, 34:1208-1215.
16. Sabate J. Nut consumption, vegetarian diets, ischemic heart disease risk, and all cause mortality: evidence from epidemiologic studies. Am J Clin Nutr 1999, 70(suppl):500S-5033S.
17. Parthasarathy S., Quinn M.T., Schwenke D.C., Carew T.E., Steinberg D. Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arterioscler Thromb & Vas Biol 1989, 9:398-404.
18. Morel D.W., Chisolm G.M. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lip Res 1989, 30:1827-1834.
19. Genest J.J., McNamara J.R., Salem D.N., Schaefer E.J. Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol 1991, 67:1185-1189.
20. Bolibar I., von Eckardstein A., Assmann G., Thompson S. Short-term prognostic value of lipid measurements for coronary events in patients with angina pectoris. Throm Hemostas 2000, 84:955-961. On behalf of the ECAT Angina Pectoris Study.
21. Tulenko T.N., Sumner A.E. The physiology of lipoproteins. J Nucl Cardiol 2002, 9:638-649.
22. Parthasarathy S., Barnett J., Fong L.G. High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochem Biophys Acta 1990, 1044:275-283.
23. Nofer J.R., Kehrel B., Fobker M., Levau B., Assmann G., von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002, 161:1-16.
24. Nagano Y., Arai H., Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci 1991, 88:6457-6461.
25. Rifici V.A., Khachadurian A.K. Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux. Atherosclerosis 1996, 127:19-26.
26. McEneny J., Trimble E.R., Young I.S. A simple method for assessing copper-mediated oxidation of very-low-density lipoprotein isolated by rapid ultracentrifugation. Ann Clin Biochem 1998, 35:504-514.
27. McDowell I.F.W., McEneny J., Trimble E.R. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem 1995, 3:167-174.
28. Hasselwander O., McEneny J., McMaster D., Fogarty D.G., Nicholls D.P., Maxwell A.P., Young I.S. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. Atherosclerosis 1999, 143:125-133.
29. Craft N.E. Carotenoid reverse-phase high performance liquid chromatography. Methods: reference compendium. Methods Enzymol 1992, 185-206.
30. Wolff S.P. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol 1994, 233:182-189.
31. McEneny J., Loughrey C.M., McNamee P.T., Trimble E.R., Young I.S. Susceptibility of VLDL to oxidation in patients on regular haemodialysis. Atherosclerosis 1997, 129:215-220.
32. Khalil A., Milochevitch C. Study of the antioxidant effect of a-tocopherol on low-density lipoprotein peroxidation induced at low and high γ-radiation dose rates. Radiat Phys Chem 2005, 72:347-353.
33. Laureaux C., Therond P., Bonnefont-Rousselot D., Troupel S., Legrand A., Delattre J. A-tocopherol enrichment of high-density lipoproteins: stabilization of hydroperoxides produced during copper oxidation. Free Radic Biol Med 1997, 22:185-194.
34. Arai H., Uchida K., Fukunaga K., Nagasaka Y., Mohri S., Furumoto H., Kuramitsu Y., Nakamura K. Effect of α-tocopherol on the oxidative modification of apolipoprotein E in human very low density lipoprotein. Biosci Biotechnol Biochem 2003, 67:402-405.
35. Kamal-Eldin A., Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996, 31:671-701.
36. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res 2005, 49:7-30.
37. Li D., Devaraj S., Fuller C., Bucala R., Jialal I. Effect of α-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies. J Lipid Res 1996, 37:1978-1986.
38. Esterbauer H., Dieber-Rotheneder M., Striegel G., Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1991, 53:314S-321S.
39. Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metabolism 2008.
40. McCall M.R., Tang J.Y., Bielicki J.K., Forte T.M. Inhibition of lecithin-cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes. Arterioscler Thromb Vasc Biol 1995, 15:1599-1606.
41. McCall M.R., van deb Berg J.J., Kuypers F.A., Tribble D.L., Krauss R.M., Knoff L.J., Forte T.M. Modification of LCAT activity and HDL structure: new links between cigarette smoke and coronary heart disease risk. Arterioscler Thromb Vasc Biol 1994, 14:248-253.
42. Traber M.G., Kayden H.J. Preferential incorporation of alpha-tocopherol vs. gamma tocopherol in human lipoproteins. Am J Clin Nutr 1989, 49:517-526.
43. Porkkala-Sarataho E.K., Nyyssonen M.K., Kaikkonen J.E., Poulsen H.E., Hayyn E.M., Salonen R.M., Salonen J.T. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg α-tocopherol on the oxidation resistance of atherogenic lipoproteins. Am J Clin Nutr 1998, 68:1034-1041.
44. Dieber-Rothender M., Puhl H., Waeg G., Striegl G., Esterbauer H. Effect of oral supplementation with d-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991, 32:1325-1332.
45. Arrol S., Mackness M.I., Durrington P.N. Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity. Atherosclerosis 2000, 150:129-134.
46. Raveh O., Pinchuk I., Schnitzer E., Fainaru M., Schaffer Z., Lichtenberg D. Kinetic analysis of copper-induced peroxidation of HDL, autoaccelerated and tocopherol-mediated peroxidation. Free Radic Biol Med 2000, 29:131-146.